Skip to main content

Table 2 Factors associated with insulin resistance

From: Insulin resistance and associated factors among HIV-infected patients in sub-Saharan Africa: a cross sectional study from Cameroon

Variables

Modalities

IR + (n = 214)

IR - (n = 238)

Crude odds ratio (95% CI)

p

aAge and sex adjusted odds ratio (95% CI)

p

Gender

- Male

36 (16.8)

55 (23.1)

0.67 (0.37–1.44)

0.355

  

- Female

178 (83.2)

183 (76.9)

1

 

Age

- ≥ 46

84 (39.3)

90 (37.8)

1,06 (0.54–3.68)

0.480

  

- < 46

130 (60.7)

148 (62.2)

1

 

HIV duration

≥ 12 months

194 (90.7)

224 (94.1)

0.61 (0.32–1.23)

0.613

0.73 (0.29–1.82)

0.500

< 12 months

20 (9.3)

14 (5.9)

1

1

 

ART

- yes

194 (90.7)

206 (86.6)

1.51 (0.54–3.68)

0.480

1.27 (047–3.41)

0.634

- no

20 (9.3)

32 (13.4)

1

1

 

1st line with NNRTIs

- yes

211 (98.6)

162 (68.1)

1.40 (0.76–1.02)

0.372

0.92 (0.30–1.70)

0.457

 

- no

13 (1.4)

14 (31.9)

1

 

1

 

2nd line with PIs

- yes

10 (4.7)

17 (7.1)

0.64 (0.15–2.84)

0.722

0.66 (0.15–2.87)

0.576

- no

179 (95.3)

194 (92.9)

1

1

 

Metabolic syndrome

- yes

35 (16.4)

18 (7.6)

2.39 (0.84–4.28)

0.120

1.79 (0.76–4.19)

0.178

- no

179 (83.6)

220 (92.4)

1

1

Hypertension

- yes

38 (17.8)

22 (9.2)

2.12 (0.96–3.92)

0.064

1.89 (0.92–3.85)

0.079

- no

176 (82.2)

216 (90.8)

1

1

Diabetes

- yes

7 (3.3)

2 (0.8)

4.00 (1.02–71.20)

0.027

8.96 (1.06–76.21)

0.044

- no

207 (96.7)

236 (99.2)

1

1

Obesity

- yes

62 (29.0)

26 (10.9)

3.32 (1.30–4.84)

0.006

2.50 (1.24–5.06)

0.011

- no

152 (71.0)

212 (89.1)

1

1

Abdominal obesity

- yes

112 (52.3)

83 (34.9)

2.05 (1.17–4.40)

0.025

2.45 (1.03–4.89)

0.041

- no

102 (47.7)

155 (65.1)

1

1

Dyslipidemia

- yes

65 (30.4)

88 (37.0)

0.74 (0.37–1.35)

0.286

0.72 (0.37–1.40)

0.337

- no

149 (69.6)

150 (63.0)

1

1

 

CD4 count

- ≥ 350

89 (41.6)

101 (42.4)

1.30 (0.60–2.85)

0.508

1.31 (0.59–2.89)

0.508

- < 350

57 (58.4)

84 (57.6)

1

1

Detectable viral load

- yes

8 (3.7)

4 (1.7)

2.50 (0.20–31.80)

0.583

/

/

- no

32 (96.3)

40 (98.3)

1

1

 
  1. aAdjusted for: age and gender. Factors are presented as count (percentage)
  2. ART antiretroviral therapy, NNRTIs non-nucleoside reverse transcriptase inhibitors, IR + participants with insulin resistance, IR- participants without insulin resistance
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X